BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION

Medicare/Medicaid MMM

21st Century Cures/ Senate Innovation for Healthier Americans ---H.R. 34: The 21st Century Cures Act ---Patient Access to Approved Drugs Reimbursement for Innovative Products ---CMMI Medicare Part B Proposed Demonstration Project ---Medicare Part B Physician-Administered Products ---Value-based Contracting and Communications

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Office of Management & Budget (OMB); Natl Institutes of Health (NIH); Office of Science & Technology Policy (OSTP); U.S. Trade Representative (USTR); Environmental Protection Agency (EPA); Agriculture, Dept of (USDA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 34 (114th)

Consumer Issues/Safety/Products CSP

Biosimilars ---Access to Samples for Testing ---Biosimilar User Fee Act Reauthorization and Implementation ---Brazil Biologics Regulations ---Coding ---Colombia Biologics Regulations ---Implementation of Affordable Care Act ---India Biologics Regulations ---Interchangeability and Pharmacy Substitution ---Mexico Biologics Regulations ---Naming ---S.3056: Creating and Restoring Equal Access to Equivalent Samples Act of 2016 ---CREATES Act (House Energy & Commerce Committee Discussion Draft) Drug Importation ---H.R. 5054/S.2956: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 Genetically Engineered (GE) Animals ---Amendment on GE Salmon Labeling ---Efficient Science-Based Review of Biotech Products ---H.R. 5054/S.2956: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 ---Labeling ---S. 2634: The One Health Act Review and Labeling of Food Derived from Biotechnology ---Implementation of Disclosure Law USDA/APHIS Agricultural Biotechnology Regulations ---Efficient Science-Based Review of Biotech Products ---Potential Revisions to Part 340 Regulations

Contacted: Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Environmental Protection Agency (EPA); Office of Management & Budget (OMB); Agriculture, Dept of (USDA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE; Office of Science & Technology Policy (OSTP)

Bills named: S. 3040 (114th), S. 2956 (114th), H.R. 5054 (114th), S. 2634 (114th), S. 3056 (114th), H.R. 5926 (114th)

Animals ANI

Genetically Engineered (GE) Animals ---Amendment on GE Salmon Labeling ---Efficient Science-Based Review of Biotech Products ---H.R. 5054/S.2956: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 ---Labeling ---S. 2634: The One Health Act

Contacted: U.S. Trade Representative (USTR); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA); Office of Science & Technology Policy (OSTP); Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); Office of Management & Budget (OMB); Environmental Protection Agency (EPA); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 2956 (114th), H.R. 5054 (114th), S. 2634 (114th)

Health Issues HCR

21st Century Cures/ Senate Innovation for Healthier Americans ---H.R.34: 21st Century Cures Act ---Biomarkers and Regulatory Science Improvements ---Communication with Healthcare Professionals and Payors ---Expanded Access to Investigational Drugs ---Expedited Pathways ---FDA Hiring Flexibility ---FDA Management and Financial Accountability ---Innovation Incentives ---Longitudinal Study of Chronic Diseases ---Patient Access to Approved Drugs ---Patient-Focused Drug Development ---Priority Review Voucher Programs ---Use of Real-World Evidence ---Vaccine and Anti-Microbial Resistance Product Development and Incentives ---S. 1878: Advancing Hope Act of 2015 ---S. 195: PATH Act ---S. 2055/H.R. 3299: Medical Countermeasures Innovation Act of 2015 ---S. 2512: Adding Zika Virus to the FDA Priority Review Voucher Program Act ---S. 524: Comprehensive Addiction and Recovery Act of 2016 ---H.R. 4762: Reliable and Effective Growth for Regenerative Health Options that Improve Wellness (REGROW) Act ---S. 3239/H.R. 5858: RACE for Children Act 340B Drug Pricing Program ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 ---Implementation of Affordable Care Act ---Program Implementation & Oversight Biodefense Research, Development and Procurement Issues (Non-Funding) ---S. 2055/H.R. 3299: Medical Countermeasures Innovation Act of 2015 Biosimilars ---Access to Samples for Testing ---Biosimilar User Fee Act Reauthorization and Implementation ---Brazil Biologics Regulations ---Coding ---Colombia Biologics Regulations ---Implementation of Affordable Care Act ---India Biologics Regulations ---Interchangeability and Pharmacy Substitution ---Mexico Biologics Regulations ---Naming ---S.3056: Creating and Restoring Equal Access to Equivalent Samples Act of 2016 ---CREATES Act (House Energy & Commerce Committee Discussion Draft) Drug Evaluation and Review ---Implementation of the FDA Safety and Innovation Act ---Reauthorization of the Prescription Drug User Fee Act ---ADAPT Act (House Discussion Draft) ---Compassionate Use/Expanded Access ---H.R. 2029: The Patient Choice Act ---H.R. 4475: Compassionate Freedom of Choice Act ---S. 2912: Trickett Wendler Right to Try Act of 2016 Drug Importation ---H.R. 5054/S.2956: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 Drug Manufacturing, Quality & Distribution ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 ---Vial and Dose Size Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 ---H.R.5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act for 2017, and Zika Response and Preparedness Act ---Supplemental Funding for Combating Zika Funding for the Centers for Disease Control and Prevention Vaccine Programs ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 Funding for FDA ---H.R. 5054/S.2956: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 Funding for National Institutes of Health ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 ---H.R.5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act for 2017, and Zika Response and Preparedness Act ---Supplemental Funding for Combating Zika Gene Editing Technologies ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 Generic Drug Entry ---CREATES Act (House Energy & Commerce Committee Discussion Draft) ---S. 2615: Increasing Competition in Pharmaceuticals Act ---S.3056: Creating and Restoring Equal Access to Equivalent Samples Act of 2016 Independent Payment Advisory Board Orphan Drug Act Tax Credit Precision Medicine Initiative Reimbursement for Innovative Products ---CMMI Medicare Part B Proposed Demonstration Project ---Medicare Part B Physician-Administered Products ---Value-based Contracting and Communications TransPacific Partnership ---Data and Intellectual Property Protection for Pharmaceuticals UN High Level Commission on Access to Medicines Vaccines and Infectious Diseases ---H.R. 3299: Strengthening Public Health Emergency Response Act ---H.R.5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act for 2017, and Zika Response and Preparedness Act ---S. 2512: Adding Zika Virus to the FDA Priority Review Voucher Program Act ---Supplemental Funding for Combating Zika ---Vaccine Injury Compensation Program ---Vaccine Safety

Contacted: Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); Office of Management & Budget (OMB); Office of Science & Technology Policy (OSTP); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA); SENATE

Bills named: S. 2912 (114th), H.R. 34 (114th), S. 524 (114th), S. 1878 (114th), S. 2956 (114th), S. 2055 (114th), S. 2615 (114th), S. 3056 (114th), H.R. 3299 (114th), S. 195 (114th), H.R. 5926 (114th), H.R. 5858 (114th), H.R. 5325 (114th), S. 3040 (114th), S. 3239 (114th), H.R. 4475 (114th), H.R. 2029 (114th), H.R. 5054 (114th), H.R. 4762 (114th), S. 2512 (114th)

Trade (domestic/foreign) TRD

Biosimilars ---Brazil Biologics Regulations ---Colombia Biologics Regulations ---India Biologics Regulations ---Mexico Biologics Regulations Drug Importation ---H.R. 5054/S.2956: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 Foreign Agricultural Biotechnology Laws and Regulations ---Asynchrony Approvals ---China Biotechnology Regulations ---EU Ag-Biotech Policies and Regulations TransPacific Partnership ---Data and Intellectual Property Protection for Pharmaceuticals UN High Level Commission on Access to Medicines

Contacted: HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Environmental Protection Agency (EPA); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Office of Science & Technology Policy (OSTP); Agriculture, Dept of (USDA); Office of Management & Budget (OMB)

Bills named: H.R. 5054 (114th), S. 2956 (114th), S. 3040 (114th), H.R. 5926 (114th)

Agriculture AGR

Adventitious Presence (Low Level Presence) ---International Low Level Presence Policies Foreign Agricultural Biotechnology Laws and Regulations ---Asynchrony Approvals ---China Biotechnology Regulations ---EU Ag-Biotech Policies and Regulations Genetically Engineered (GE) Animals ---Amendment on GE Salmon Labeling ---Efficient Science-Based Review of Biotech Products ---H.R. 5054/S.2956: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 ---Labeling ---S. 2634: The One Health Act Potential Regulation of New Genetic Modification Technologies Review and Labeling of Food Derived from Biotechnology ---Implementation of Disclosure Law Review of the Federal Coordinated Framework for Biotechnology Products USDA/APHIS Agricultural Biotechnology Regulations ---Efficient Science-Based Review of Biotech Products ---Potential Revisions to Part 340 Regulations

Contacted: Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Environmental Protection Agency (EPA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Office of Science & Technology Policy (OSTP); Agriculture, Dept of (USDA); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); SENATE; U.S. Trade Representative (USTR)

Bills named: S. 2634 (114th), H.R. 5054 (114th), S. 2956 (114th)

Taxation/Internal Revenue Code TAX

Biofuels (Non-Funding) ---Production Tax Credit Extension Capital Formation Investment Incentives ---Reform of Capital Gains Rules ---Reform of Net Operating Loss Rules ---Reform of Passive Loss Rules ---S. 341: Start-up Jobs and Innovation Act ---H.R. 2179: PARTNER Act ---S. 537: COMPETE Act Inversions ---H.R.5485-S.3067: Financial Services and General Government Appropriations Act for FY 2017 Treatment of Financial Interests as Stock or Indebtedness ---Section 385 Proposed Regulations Orphan Drug Act Tax Credit No sub-issues Renewable Chemicals/Bio-based Products (Non-Funding) ---Investment Tax Credit for Renewable Chemicals and Bio-based Products ---New Production Tax Credit ---H.R. 3390: Qualifying Renewable Chemicals Production or Investment Tax Credit Act ---S. 2271: The Renewable Chemical Production Tax Credit Act

Contacted: Office of Science & Technology Policy (OSTP); Centers For Medicare and Medicaid Services (CMS); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); SENATE; Natl Institutes of Health (NIH); Agriculture, Dept of (USDA)

Bills named: S. 2271 (114th), H.R. 2179 (114th), S. 537 (114th), S. 341 (114th), H.R. 5485 (114th), S. 3067 (114th), H.R. 3390 (114th)

Copyright/Patent/Trademark CPT

Bayh-Dole Act/Tech Transfer ---March-In Rights Drug Patent Settlements ---S. 2019: Preserve Access to Affordable Generics Act of 2015 Inter Partes Review ---H.R.5485-S.3067: Financial Services and General Government Appropriations Act for FY 2017 ---Implementation of the America Invents Act of 2011 ---S.1137: The PATENTS Act of 2015 Patent Reform ---H.R. 9: Innovation Act TransPacific Partnership ---Data and Intellectual Property Protection for Pharmaceuticals UN High Level Commission on Access to Medicines

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Office of Science & Technology Policy (OSTP); Natl Institutes of Health (NIH); Agriculture, Dept of (USDA); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); Environmental Protection Agency (EPA)

Bills named: S. 3067 (114th), S. 2019 (114th), H.R. 9 (114th), S. 1137 (114th), H.R. 5485 (114th)

Small Business SMB

Capital Formation Investment Incentives ---Reform of Capital Gains Rules ---Reform of Net Operating Loss Rules ---Reform of Passive Loss Rules ---S. 341: Start-up Jobs and Innovation Act ---S. 537: COMPETE Act ---H.R. 2179: PARTNER Act Capital Market Enhancements ---Financial CHOICE Act (House Discussion Draft) ---H.R. 1675/S. 576: Encouraging Employee Ownership Act ---H.R. 1675: Capital Markets Improvement Act ---H.R. 2187: Fair Investment Opportunities for Professional Experts Act ---H.R. 2354: Streamlining Excessive and Costly Regulations Review Act ---H.R. 2357: Accelerating Access to Capital Act ---H.R. 3784/S.2867: Securities & Exchange Commission Small Business Advocate Act ---H.R. 4168: Small Business Capital Formation Enhancement Act ---H.R. 4638: Main Street Growth Act ---H.R. 6427: Creating Financial Prosperity for Businesses and Investors Act ---PCAOB Audit Cost Increases Legislative Amendments to SEC Rule 12b-2 Filing Status Definitions ---Financial CHOICE Act (House Discussion Draft) ---H.R. 5311: Corporate Governance Reform and Transparency Act ---Impact of Policies on Small Public Companies Proxy Advisory Services ---Financial CHOICE Act (House Discussion Draft) ---H.R. 5311: Corporate Governance Reform and Transparency Act ---Impact of Policies on Small Public Companies Reform of SEC Regulation D ---Financial CHOICE Act (House Discussion Draft) ---H.R. 4498/S. 978: HALOS Act Sarbanes Oxley Section 404 (b) ---Financial CHOICE Act (House Discussion Draft) ---H.R. 4139: Fostering Innovation Act ---PCAOB Audit Cost Increases ---Small Issuer Exemption Short Selling Transparency ---H.R.5485-S.3067: Financial Services and General Government Appropriations Act for FY 2017 Stock Exchange Tick Size XBRL Exemption for Small Public Companies ---Financial CHOICE Act (House Discussion Draft) ---H.R. 1675: Capital Markets Improvement Act ---H.R. 1965: Small Company Disclosure Simplification Act

Contacted: SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Environmental Protection Agency (EPA); Office of Management & Budget (OMB); Agriculture, Dept of (USDA); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Office of Science & Technology Policy (OSTP); Health & Human Services, Dept of (HHS)

Bills named: H.R. 4168 (114th), H.R. 2357 (114th), H.R. 5311 (114th), H.R. 5485 (114th), H.R. 1965 (114th), S. 576 (114th), H.R. 4638 (114th), H.R. 3784 (114th), S. 537 (114th), S. 2867 (114th), H.R. 2187 (114th), H.R. 4139 (114th), S. 978 (114th), H.R. 6427 (114th), H.R. 2354 (114th), H.R. 2179 (114th), S. 341 (114th), S. 3067 (114th), H.R. 1675 (114th), H.R. 4498 (114th)

Budget/Appropriations BUD

Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 ---H.R.5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act for 2017, and Zika Response and Preparedness Act ---Supplemental Funding for Combating Zika Funding for Biofuels ---H.R. 4909/S.2943: National Defense Authorization Act (NDAA) for FY 2017 ---H.R. 5054/S.2956: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 ---H.R. 5293/S.3000: Department of Defense Appropriations Act for FY 2017 Funding for FDA ---H.R. 5054/S.2956: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 Funding for National Institutes of Health ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 ---H.R.5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act for 2017, and Zika Response and Preparedness Act ---Supplemental Funding for Combating Zika Funding for Renewable Chemicals/Bio-based Products ---H.R. 4909/S.2943: National Defense Authorization Act (NDAA) for FY 2017 ---H.R. 5293/S.3000: Department of Defense Appropriations Act for FY 2017 Funding for the Centers for Disease Control and Prevention Vaccine Programs ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Environmental Protection Agency (EPA); Agriculture, Dept of (USDA); U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Office of Science & Technology Policy (OSTP)

Bills named: S. 3000 (114th), H.R. 4909 (114th), H.R. 5293 (114th), S. 3040 (114th), H.R. 5054 (114th), H.R. 5926 (114th), S. 2943 (114th), S. 2956 (114th), H.R. 5325 (114th)

Chemicals/Chemical Industry CHM

Funding for Renewable Chemicals/Bio-based Products ---H.R. 4909/S.2943: National Defense Authorization Act (NDAA) for FY 2017 ---H.R. 5293/S.3000: Department of Defense Appropriations Act for FY 2017 Renewable Chemicals/Bio-based Products (Non-Funding) ---Expansion of Master Limited Partnerships to Renewable Chemicals ---Investment Tax Credit for Renewable Chemicals and Bio-based Products ---New Production Tax Credit ---Reauthorization of USDA Bio-Preferred Program ---S. 1656/H.R. 2883: Master Limited Partnership Parity Act ---S. 2271: The Renewable Chemical Production Tax Credit Act ---H.R. 3390: Qualifying Renewable Chemicals Production or Investment Tax Credit Act

Contacted: Office of Science & Technology Policy (OSTP); Food & Drug Administration (FDA); SENATE; Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Environmental Protection Agency (EPA); U.S. Trade Representative (USTR)

Bills named: S. 2943 (114th), S. 3000 (114th), H.R. 2883 (114th), H.R. 5293 (114th), H.R. 4909 (114th), H.R. 3390 (114th), S. 2271 (114th), S. 1656 (114th)

Energy/Nuclear ENG

Biofuels (Non-Funding) ---Production Tax Credit Extension Cartagena Biosafety Protocol ---Nagoya Protocol on Access and Benefit sharing Funding for Biofuels ---H.R. 4909/S.2943: National Defense Authorization Act (NDAA) for FY 2017 ---H.R. 5054/S.2956: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 ---H.R. 5293/S.3000: Department of Defense Appropriations Act for FY 2017 Renewable Fuel Standard ---EPA Proposed Rule for the Renewable Fuel Standard Program: Standards for 2017 and Biomass-Based Diesel Volume for 2018 ---H.R. 1736/S. 1239: To amend the Clean Air Act with respect to the ethanol waiver for the Reid vapor pressure limitations under such Act Review of the Federal Coordinated Framework for Biotechnology Products

Contacted: Office of Science & Technology Policy (OSTP); Natl Institutes of Health (NIH); Office of Management & Budget (OMB); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); SENATE; Agriculture, Dept of (USDA); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA)

Bills named: S. 2943 (114th), S. 2956 (114th), H.R. 1736 (114th), S. 1239 (114th), H.R. 5054 (114th), H.R. 5293 (114th), H.R. 4909 (114th), S. 3000 (114th)

Food Industry (safety, labeling, etc.) FOO

Genetically Engineered (GE) Animals ---Amendment on GE Salmon Labeling ---Efficient Science-Based Review of Biotech Products ---H.R. 5054/S.2956: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 ---Labeling ---S. 2634: The One Health Act Review and Labeling of Food Derived from Biotechnology ---Implementation of Disclosure Law

Contacted: Environmental Protection Agency (EPA); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Agriculture, Dept of (USDA); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Natl Institutes of Health (NIH); Office of Science & Technology Policy (OSTP); SENATE

Bills named: S. 2634 (114th), H.R. 5054 (114th), S. 2956 (114th)

Fuel/Gas/Oil FUE

Biofuels (Non-Funding) ---Production Tax Credit Extension Cartagena Biosafety Protocol ---Nagoya Protocol on Access and Benefit sharing Funding for Biofuels ---H.R. 4909/S.2943: National Defense Authorization Act (NDAA) for FY 2017 ---H.R. 5054/S.2956: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 ---H.R. 5293/S.3000: Department of Defense Appropriations Act for FY 2017 Renewable Fuel Standard ---EPA Proposed Rule for the Renewable Fuel Standard Program: Standards for 2017 and Biomass-Based Diesel Volume for 2018 ---H.R. 1736/S. 1239: To amend the Clean Air Act with respect to the ethanol waiver for the Reid vapor pressure limitations under such Act Review of the Federal Coordinated Framework for Biotechnology Products

Contacted: Office of Science & Technology Policy (OSTP); Office of Management & Budget (OMB); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Agriculture, Dept of (USDA); Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 3000 (114th), H.R. 4909 (114th), S. 2956 (114th), H.R. 5054 (114th), S. 2943 (114th), S. 1239 (114th), H.R. 5293 (114th), H.R. 1736 (114th)

Homeland Security HOM

Biodefense Research, Development and Procurement Issues (Non-Funding) ---S. 2055/H.R. 3299: Medical Countermeasures Innovation Act of 2015 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 ---H.R.5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act for 2017, and Zika Response and Preparedness Act ---Supplemental Funding for Combating Zika

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Office of Science & Technology Policy (OSTP); Office of Management & Budget (OMB); U.S. Trade Representative (USTR); Agriculture, Dept of (USDA); Health & Human Services, Dept of (HHS); Environmental Protection Agency (EPA); Natl Institutes of Health (NIH); Food & Drug Administration (FDA)

Bills named: H.R. 5325 (114th), S. 3040 (114th), H.R. 3299 (114th), H.R. 5926 (114th), S. 2055 (114th)

Medical/Disease Research/Clinical Labs MED

21st Century Cures/ Senate Innovation for Healthier Americans ---H.R. 34: The 21st Century Cures Act ---Longitudinal Study of Chronic Diseases Biodefense Research, Development and Procurement Issues (Non-Funding) ---S. 2055/H.R. 3299: Medical Countermeasures Innovation Act of 2015 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 ---H.R.5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act for 2017, and Zika Response and Preparedness Act ---Supplemental Funding for Combating Zika Funding for National Institutes of Health ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 ---H.R.5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act for 2017, and Zika Response and Preparedness Act ---Supplemental Funding for Combating Zika Gene Editing Technologies ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 Precision Medicine Initiative

Contacted: Natl Institutes of Health (NIH); Office of Management & Budget (OMB); Agriculture, Dept of (USDA); Food & Drug Administration (FDA); Environmental Protection Agency (EPA); Health & Human Services, Dept of (HHS); Office of Science & Technology Policy (OSTP); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR)

Bills named: H.R. 3299 (114th), H.R. 34 (114th), H.R. 5325 (114th), H.R. 5926 (114th), S. 2055 (114th), S. 3040 (114th)